Sfoglia per Autore
[Deep vein thrombosis: present and future drugs].
1999 Agnelli, Giancarlo
Building effective prophylaxis of deep vein thrombosis in the outpatient setting. Blood Coagul Fibrinolysis.
1999 Agnelli, Giancarlo; Taliani, Mr; Verso, Melina
[New antithrombotic drugs].
1999 Taliani, Mr; Agnelli, Giancarlo
The rationale for long-term prophylaxis of venous thromboembolism
2000 Agnelli, Giancarlo; Mancini, Giovanni Battista; Biagini, D.
Clinical and economic aspects of managing venous thromboembolism in the outpatient setting
2001 Agnelli, Giancarlo; Becattini, Cecilia
Antithrombotic therapy for venous thromboembolic disease
2001 Hyers, T. M; Agnelli, Giancarlo; Hull, R. D.; Morris, T. A.; Samama, M.; Tapson, V.; Weg, J. G.
Antithrombotic therapy for venous thrombosis disease.
2001 Hyers, T.; Agnelli, Giancarlo; Hull, R.; Morris, T.; Samama, M.; Tapson, V.; Weg, J.
Intravenous thrombolysis in acute myocardial infarction
2001 Ohman, E.; Harrington, R.; Cannon, C.; Agnelli, Giancarlo; Cairns, J.; Kennedy, J.
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332)
2001 Iorio, Alfonso; Agnelli, Giancarlo
Profilassi della trombosi venosa profonda in neurochirurgia
2001 Iorio, Alfonso; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio
Rationale and design of the grace (global registry of acute coronary events) project: A multinational registry of patients hospitalized with acute coronary syndromes
2001 Fox, K. A. A.; Gore, J. M.; Eagle, K. A.; Steg, P. G.; Agnelli, Giancarlo; Avezum, A.; Paulo, S.; Brieger, D.; Budaj, A.; Cannon, C. P.; Goldberg, R. J; Goodman, S.; Gulba, D. C.; Volhard, F.; Granger, C.; Kennelly, B. M.; Gurfinkel, E.; López Sendón, J.; Klein, W.; Montalescot, G.; Van de Werf, F.
Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism
2001 Zonzin, P.; Agnelli, Giancarlo; Casazza, F.; Favretto, G.; Giuntini, C.; Morpurgo, M.; Vizza, C.
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
2001 Agnelli, Giancarlo; Prandoni, P; Santamaria, Mg; Bagatella, P; Iorio, Alfonso; Bazzan, M; Moia, M; Guazzaloca, G; Bertoldi, A; Tomasi, C; Scannapieco, G; Ageno, W; WARFARIN OPTIMAL DURATION ITALIAN TRIAL, Investigators
Risk factors for adverse short-term outcome in patients with pulmonary embolism
2001 Becattini, Cecilia; Agnelli, Giancarlo
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement
2001 Lee, A.; Agnelli, Giancarlo; Buller, H.; Ginsberg, J.; Heit, J.; Rote, W.; Vlasuk, G.; Costantini, L.; Julian, J.; Comp, P.; Van der Meer, J.; Piovella, F.; Raskob, G.; Gent, M.
Rationale for the use of platelet aggregation inhibitors in PAD patients
2001 Agnelli, Giancarlo
New pharmacologic strategies for arterial and venous thromboembolism
2001 Agnelli, Giancarlo
End points in studies on the prevention of deep vein thrombosis
2001 Sonaglia, F.; Rossi, R.; Agnelli, Giancarlo
Antithrombotic therapy for venous thromboembolic disease.
2001 Hyers, Tm; Agnelli, Giancarlo; Hull, Rd; Morris, Ta; Samama, M; Tapson, V; Weg, Jg
Risk factor for upper extremity deep vein thrombosis
2002 Verso, M.; Agnelli, Giancarlo; Nenci, Giuseppe Giorgio
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile